A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2022; you can also visit the original URL.
The file type is application/pdf.
Clinical effects of miconazole in patients with mycosis associated with various hematological diseases or with pyrexia resistant to antibiotics
各種血液疾患に伴う真菌症および抗生剤に反応しない発熱患者に対するミコナゾールの効果
1988
Chemotherapy
各種血液疾患に伴う真菌症および抗生剤に反応しない発熱患者に対するミコナゾールの効果
Preserved Fulltext
Miconazole, an antimycotic agent was administered to 23 patients with mycosis associated with severe hematological diseases or with pyrexia suspected as being mycotic in order to examine its clinical and side-effects. Subjects were 9 cases of pulmonary mycosis or mycotic pneumonia, 1 case of Candida esophagitis and 13 cases of suspected mycotic sepsis. Miconazole was given by drip infusion2 or 3 times a day at a dose of 200 to 400 mg. Clinical results were remarkably effective in 2, effective
doi:10.11250/chemotherapy1953.36.19
fatcat:7qjb2ncg5bghzou5bpbt4755wi